Overview

Aripiprazole in the Treatment of Bipolar Depression

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
A systematic open-label prospective pilot study to assess aripirazole for acute bipolar depression, with a secondary assessment of longer-term mood stabilization.
Phase:
N/A
Details
Lead Sponsor:
Cambridge Health Alliance
Collaborator:
Bristol-Myers Squibb
Treatments:
Aripiprazole